Early discharge in Mild Acute Pancreatitis. Is it possible? Observational prospective study in a tertiary-level hospital

Serra, S.; Monforte, Neus García; Borobia, Francisco Javier García; Cladera, Pere Rebasa; Pacheco, Juan Carlos García; Monzonís, Andreu Romaguera; González, Natalia Bejarano; Soto, Salvador Navarro

doi:10.1016/j.pan.2017.07.193

Cited by 12 publications

(10 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Readmission rates in studies that included all patients treated for AP ranged from 7 to 34% and varied depending on etiology, disease severity, and medical comorbidities [ [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] ], Fig. 1 .…”

Section: Resultsmentioning

confidence: 99%

“…Readmission rates in medication, post-ERCP, and hypertriglyceridemia etiologies of AP were 0–5% [ 8 , 11 , 12 , 15 ]. Among patients with mild AP readmission rates were 7–27% [ 11 , 15 , 24 , 27 , 29 , 31 ]. Readmission rates were higher in patients with severe AP or necrotizing pancreatitis (20–75%) [ 8 , 9 , 11 , 16 , 20 , 23 , 29 , 30 , 32 ].…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Readmission in acute pancreatitis: Etiology, risk factors, and opportunities for improvement

Bogan¹,

McGuire²,

Maatman³

2022

Surgery Open Science

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Readmission in acute pancreatitis: Etiology, risk factors, and opportunities for improvement

Bogan¹,

McGuire²,

Maatman³

2022

Surgery Open Science

View full text Add to dashboard Cite

“…The number of patients studied in this paper is relatively small and is a criticism of the paper. However, previous studies have assessed similar numbers of patients . Despite the relatively small number of patients, statistical analysis did identify six factors that were statistically significant.…”

Section: Discussionmentioning

confidence: 94%

“…Early discharge with a diagnosis of mild acute pancreatitis has been reported in the literature, but the value of enhanced outpatient services, for improved patient safety and satisfaction has rarely been reported. Serra Pla et al . applied five criteria for early discharge with mild acute pancreatitis, which identified 42% of their cohort (105/250 patients) for early discharge.…”

Section: Discussionmentioning

confidence: 99%

Early discharge of patients with acute pancreatitis to enhanced outpatient care

Kumar

Treacy

et al. 2018

ANZ Journal of Surgery

View full text Add to dashboard Cite

show abstract

“…This proposed study seeks to prospectively evaluate a new scope in the care of patients with MAP and is justified based on these three points: (1) patients with MAP usually achieve a complete recovery of their symptoms in less than a week with conservative management (intravenous hydration, analgesia and early diet); (2) clinical prognostic scoring systems, although criticised for their poor positive predictive value for severe AP, have an excellent negative predictive value to determine which patients will have MAP early in their hospitalisation; and (3) factors that predict hospital readmission within 30 days in AP have been studied and can be applied 8–15…”

Section: Introductionmentioning

confidence: 99%

Home care/outpatient versus hospital admission in mild acute pancreatitis: protocol of a multicentre, randomised controlled trial (PADI_2 trial)

Ramírez-Maldonado,

Rodrigo-Rodrigo,

Lopez Gordo

et al. 2023

BMJ Open

View full text Add to dashboard Cite

IntroductionAcute pancreatitis (AP) is the third most common gastrointestinal disease resulting in hospital admission, with over 70% of AP admissions being mild cases. In the USA, it costs 2.5 billion dollars annually. The most common standard management of mild AP (MAP) still is hospital admission. Patients with MAP usually achieve complete recovery in less than a week and the severity predictor scales are reliable. The aim of this study will be to compare three different strategies for the management of MAP.Methods/designThis is a randomised, controlled, three-arm multicentre trial. Patients with MAP will be randomly assigned to group A (outpatient), B (home care) or C (hospital admission). The primary endpoint of the trial will be the treatment failure rate of the outpatient/home care management for patients with MAP compared with that of hospitalised patients. The secondary endpoints will be pain relapse, diet intolerance, hospital readmission, hospital length of stay, need for intensive care unit admission, organ failure, complications, costs and patient satisfaction. The general feasibility, safety and quality checks required for high-quality evidence will be adhered to.Ethics and disseminationThe study (version 3.0, 10/2022) has been approved by the Scientific and Research Ethics Committee of the ‘Institut d’Investigació Sanitaria Pere Virgili-IISPV’ (093/2022). This study will provide evidence as to whether outpatient/home care is similar to usual management of AP. The conclusions of this study will be published in an open-access journal.Trial registration numberClinicalTrials.gov Registry (NCT05360797).

show abstract

Early discharge in Mild Acute Pancreatitis. Is it possible? Observational prospective study in a tertiary-level hospital

Cited by 12 publications

References 22 publications

Readmission in acute pancreatitis: Etiology, risk factors, and opportunities for improvement

Readmission in acute pancreatitis: Etiology, risk factors, and opportunities for improvement

Early discharge of patients with acute pancreatitis to enhanced outpatient care

Home care/outpatient versus hospital admission in mild acute pancreatitis: protocol of a multicentre, randomised controlled trial (PADI_2 trial)

Contact Info

Product

Resources

About